Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Ingrid M E Desar"'
Autor:
Gijs Hesselink, Ingrid M E Desar, Valery E P P Lemmens, Janneke E W Walraven, Rob H A Verhoeven, Renske van der Meulen, Jacobus J M van der Hoeven
Publikováno v:
BMJ Open Quality, Vol 12, Iss 1 (2023)
Background Optimal oncological care nowadays requires discussing every patient in a multidisciplinary team meeting (MDTM). The number of patients to be discussed is rising rapidly due to the increasing incidence and prevalence of cancer and the emerg
Externí odkaz:
https://doaj.org/article/6b16325acbc4489e972281468bea7f18
Autor:
Vicky L M N Soomers, Winette T A van der Graaf, Shane Zaidi, Suzanne E J Kaal, Andrew J Hayes, Bart H W B Schreuder, Robin L Jones, Ingrid M E Desar, Olga Husson
Publikováno v:
PLoS ONE, Vol 15, Iss 12, p e0243439 (2020)
IntroductionSarcomas are rare tumours. Early diagnosis is challenging, but important for local control and potentially survival and quality of life(QoL). We investigated (1)the route to diagnosis (RtD) experienced by sarcoma patients, including facto
Externí odkaz:
https://doaj.org/article/287f717f1365431cbb9a27685ac9a531
Autor:
Roos F. Bleckman, Charlotte M. S. C. Haag, Naomi Rifaela, Gerrieke Beukema, Ron H. J. Mathijssen, Neeltje Steeghs, Hans Gelderblom, Ingrid M. E. Desar, Arjen Cleven, Arja terElst, Ed Schuuring, Anna K. L. Reyners
Publikováno v:
Molecular Oncology, Vol 18, Iss 11, Pp 2658-2667 (2024)
Patients with gastro‐intestinal stromal tumors (GISTs) undergoing tyrosine kinase inhibitor therapy are monitored with regular computed tomography (CT) scans, exposing patients to cumulative radiation. This exploratory study aimed to evaluate circu
Externí odkaz:
https://doaj.org/article/24846d9179084dad86b3bdbabda1dee8
Autor:
Kim Westerdijk, Neeltje Steeghs, Casper S. J. Tacke, Winette T. A. van derGraaf, Nielka P. vanErp, Gerard vanOortmerssen, Rosella P. M. G. Hermens, Ingrid M. E. Desar, In collaboration with the Dutch Pharmacology Oncology Group (DPOG)
Publikováno v:
Cancer Medicine, Vol 12, Iss 22, Pp 21041-21056 (2023)
Abstract Background Personalized dosing based on measurement of individual drug levels and adjusting the dose accordingly can improve efficacy and decrease unnecessary toxicity of oncological treatment. For imatinib, sunitinib, and pazopanib, this th
Externí odkaz:
https://doaj.org/article/f526d700fa4545ab81c035bd276d9978
Autor:
Stefanie D. Krens, Nielka P. van Erp, Stefanie L. Groenland, Dirk Jan A. R. Moes, Sasja F. Mulder, Ingrid M. E. Desar, Tom van der Hulle, Neeltje Steeghs, Carla M. L. van Herpen
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-12 (2022)
Abstract Aim In the registration trial, cabozantinib exposure ≥ 750 ng/mL correlated to improved tumor size reduction, response rate and progression free survival (PFS) in patients with metastatic renal cell cancer (mRCC). Because patients in routi
Externí odkaz:
https://doaj.org/article/f27b5243be1f49888ffdb384331fa067
Autor:
Anke E. M. van Erp, Melissa H. S. Hillebrandt-Roeffen, Niek F. H. N. van Bree, Tim A. Plüm, Uta. E. Flucke, Ingrid M. E. Desar, Emmy D. G. Fleuren, Winette T. A. van der Graaf, Yvonne M. H. Versleijen-Jonkers
Publikováno v:
Sarcoma, Vol 2022 (2022)
Desmoplastic small round cell tumors (DSRCTs), Ewing sarcoma (ES), and alveolar and embryonal rhabdomyosarcoma (ARMS and ERMS) are malignant sarcomas typically occurring at young age, with a poor prognosis in the metastatic setting. New treatment opt
Externí odkaz:
https://doaj.org/article/54526dee4e644555857ded7c69c21881
Autor:
Mahmoud Mohammadi, Nikki S. IJzerman, Dide den Hollander, Roos F. Bleckman, Astrid W. Oosten, Ingrid M. E. Desar, An K. L. Reyners, Neeltje Steeghs, Hans Gelderblom
Publikováno v:
Targeted Oncology, 18, 415-423
Targeted oncology. SPRINGER
Targeted Oncology, 18, 3, pp. 415-423
Targeted Oncology, 18(3), 415-423. Springer Paris
Targeted oncology. SPRINGER
Targeted Oncology, 18, 3, pp. 415-423
Targeted Oncology, 18(3), 415-423. Springer Paris
Contains fulltext : 292913.pdf (Publisher’s version ) (Open Access) BACKGROUND: Patients with unresectable and metastasized gastrointestinal stromal tumor (GIST) experienced a remarkable improvement of progression-free survival (PFS) and overall su
Autor:
Janneke E W, Walraven, Theodora M, Ripping, Jorg R, Oddens, Bas W G, van Rhijn, Catharina A, Goossens-Laan, Maarten C C M, Hulshof, Lambertus A, Kiemeney, J A, Witjes, Valery E P P, Lemmens, Jacobus J M, van der Hoeven, Ingrid M E, Desar, Katja K H, Aben, Lisa M C, van Hoogstraten
Publikováno v:
BJU International, 131, 2, pp. 244-252
BlaZIB Study Group 2022, ' The influence of multidisciplinary team meetings on treatment decisions in advanced bladder cancer ', BJU International . https://doi.org/10.1111/bju.15856
BJU International, 131, 244-252
BJU International. Wiley-Blackwell
BJU international. Wiley-Blackwell
BlaZIB Study Group 2022, ' The influence of multidisciplinary team meetings on treatment decisions in advanced bladder cancer ', BJU International . https://doi.org/10.1111/bju.15856
BJU International, 131, 244-252
BJU International. Wiley-Blackwell
BJU international. Wiley-Blackwell
Contains fulltext : 291201.pdf (Publisher’s version ) (Open Access) OBJECTIVES: To investigate the role of specialised genitourinary multidisciplinary team meetings (MDTMs) in decision-making and identify factors that influence the probability of r
Autor:
Mahmoud Mohammadi, Thekla M. Jansen-Werkhoven, Nikki S. Ijzerman, Dide den Hollander, Roos F. Bleckman, Astrid W. Oosten, Ingrid M. E. Desar, An K. L. Reyners, Neeltje Steeghs, Hans Gelderblom
Publikováno v:
Targeted Oncology, 17, 6, pp. 627-634
Targeted oncology, 17(6), 627-634. SPRINGER
Targeted Oncology, 17, 627-634
Targeted Oncology, 17(6), 627-634. Springer Paris
Targeted Oncology, 17(6), 627-634. SPRINGER
Targeted oncology, 17(6), 627-634. SPRINGER
Targeted Oncology, 17, 627-634
Targeted Oncology, 17(6), 627-634. Springer Paris
Targeted Oncology, 17(6), 627-634. SPRINGER
Contains fulltext : 287667.pdf (Publisher’s version ) (Open Access) BACKGROUND: The prognosis of patients with advanced gastrointestinal stromal tumor (GIST) has improved greatly after the introduction of imatinib. However, primary or secondary res
Autor:
Gorp, Tess Tomassen, Yvonne M. H. Versleijen-Jonkers, Melissa H. S. Hillebrandt-Roeffen, Patricia H. J. Van Cleef, Thijs van Dalen, Marije E. Weidema, Ingrid M. E. Desar, Uta Flucke, Joost M. van
Publikováno v:
Cancers; Volume 15; Issue 13; Pages: 3304
Epithelioid hemangioendothelioma (EHE) is an extremely rare vascular sarcoma with variable aggressive clinical behavior. In this retrospective study, we aimed to investigate prognostic factors based on clinicopathologic findings in a molecularly/immu